Eyenovia Inc - ESG Rating & Company Profile powered by AI
This analysis of Eyenovia Inc leverages intelligence from across the internet and also from public documents by Eyenovia Inc. The ESG assessment for Eyenovia Inc indicates the company's reporting of the United Nations Sustainable Development Goals. Complete ESG assessment of Eyenovia Inc are accessed by signing in.
Eyenovia Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 0.0, social score of 1.6 and governance score of 2.0.
1.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
| 1755 | Trimurthi Ltd | 1.3 | Low |
| 1779 | Eyenovia Inc | 1.2 | Low |
| 1779 | Cell Biotech Co Ltd | 1.2 | Low |
| 1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Eyenovia Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Eyenovia Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Eyenovia Inc report the average age of the workforce?
Sign up for free to unlockDoes Eyenovia Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Eyenovia Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Eyenovia Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Eyenovia Inc offer flexible work?
Sign up for free to unlockDoes Eyenovia Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Eyenovia Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Eyenovia Inc conduct supply chain audits?
Sign up for free to unlockDoes Eyenovia Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Eyenovia Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Eyenovia Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Eyenovia Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Eyenovia Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Eyenovia Inc disclose water use targets?
Sign up for free to unlockDoes Eyenovia Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Eyenovia Inc have a product recall in the last two years?
Sign up for free to unlockDoes Eyenovia Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Eyenovia Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Eyenovia Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Eyenovia Inc disclose parental leave metrics?
Sign up for free to unlockDoes Eyenovia Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Eyenovia Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Eyenovia Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Eyenovia Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Eyenovia Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Eyenovia Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Eyenovia Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Eyenovia Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Eyenovia Inc disclose its waste policy?
Sign up for free to unlockDoes Eyenovia Inc report according to TCFD requirements?
Sign up for free to unlockDoes Eyenovia Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Eyenovia Inc disclose energy use targets?
Sign up for free to unlockDoes Eyenovia Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Eyenovia Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Eyenovia Inc
These potential risks are based on the size, segment and geographies of the company.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.